Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$12.29
-0.64-4.95%
Last update: Oct 13, 4:00 PM
$13.00
0.070.54%
Trevi Therapeutics Inc (TRVI) Stock Price, Quote, News & History
TRVINASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Trevi Therapeutics (NASDAQ:TRVI) through any online brokerage.
Other companies in Trevi Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Trevi Therapeutics has a consensus price target of $22.28.
The stock price for Trevi Therapeutics (NASDAQ: TRVI) is $12.29 last updated October 13, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Trevi Therapeutics.
Trevi Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Trevi Therapeutics.
Trevi Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
